Neoantigens Market Forecast to Grow to US$ 5,607.32 Million by 2034
Neoantigens are newly formed antigenic determinants generated from cancer-specific DNA mutations that alter protein structure within tumor cells. These altered peptides are processed and presented on the tumor cell surface through major histocompatibility complex molecules, enabling targeted immune recognition. Their exclusivity to malignant cells positions them as powerful biomarkers and...
0 Комментарии 0 Поделились 24 Просмотры 0 предпросмотр
Спонсоры
Спонсоры
Спонсоры